Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT200 in advanced esophageal squamous cell carcinoma
NCT03817567Phase 2Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- Jul 2018
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sct200 in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
sct200
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT03817567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03817567.